Jay  Pepose net worth and biography

Jay Pepose Biography and Net Worth

Director of Ocuphire Pharma
Dr. Jay Pepose is the Director of Ocuphire Pharma.

How do I contact Jay Pepose?

The corporate mailing address for Dr. Pepose and other Ocuphire Pharma executives is 15245 SHADY GROVE ROAD SUITE 455, ROCKVILLE MD, 20850. Ocuphire Pharma can also be reached via phone at (248) 681-9815 and via email at [email protected]. Learn More on Jay Pepose's contact information.

Has Jay Pepose been buying or selling shares of Ocuphire Pharma?

Jay Pepose has not been actively trading shares of Ocuphire Pharma during the last ninety days. Most recently, on Monday, December 13th, Jay Pepose bought 8,250 shares of Ocuphire Pharma stock. The stock was acquired at an average cost of $3.65 per share, with a total value of $30,112.50. Learn More on Jay Pepose's trading history.

Who are Ocuphire Pharma's active insiders?

Ocuphire Pharma's insider roster includes James Manuso (Director), and Jay Pepose (Director). Learn More on Ocuphire Pharma's active insiders.

Are insiders buying or selling shares of Ocuphire Pharma?

During the last twelve months, Ocuphire Pharma insiders bought shares 3 times. They purchased a total of 37,000 shares worth more than $74,100.00. The most recent insider tranaction occured on March, 21st when COO Joseph K Schachle bought 2,000 shares worth more than $4,100.00. Insiders at Ocuphire Pharma own 8.7% of the company. Learn More about insider trades at Ocuphire Pharma.

Information on this page was last updated on 3/21/2024.

Jay Pepose Insider Trading History at Ocuphire Pharma

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/13/2021Buy8,250$3.65$30,112.50View SEC Filing Icon  
9/13/2021Buy12,631$4.75$59,997.25View SEC Filing Icon  
See Full Table

Jay Pepose Buying and Selling Activity at Ocuphire Pharma

This chart shows Jay Pepose's buying and selling at Ocuphire Pharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Ocuphire Pharma Company Overview

Ocuphire Pharma logo
Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate for dim light or night vision disturbances; and for pharmacologically induced mydriasis and presbyopia. The company also develops APX3330, a twice-a-day oral tablet to target pathways relevant to retinal and choroidal vascular diseases, such as diabetic retinopathy and diabetic macular edema; and APX2009 and APX2014 second generation preclinical product candidates and analogs of APX3330. The company is headquartered in Farmington Hills, Michigan.
Read More

Today's Range

Now: $2.01
Low: $1.99
High: $2.03

50 Day Range

MA: $2.43
Low: $1.89
High: $2.79

2 Week Range

Now: $2.01
Low: $1.85
High: $6.60

Volume

121,779 shs

Average Volume

197,631 shs

Market Capitalization

$49.87 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.36